A review of implantable biosensors for closed-loop glucose control and other drug delivery applications
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Closed-loop drug delivery promises autonomous control of pharmacotherapy through the continuous monitoring of biomarker levels. For decades, researchers have strived for portable closed-loop systems capable of treating ambulatory patients with chronic conditions such as diabetes mellitus. After years of development, the first of these systems have left the laboratory and entered commercial use. This long-awaited advance reflects recent development of chronically stable implantable biosensors able to accurately measure biomarker levels in vivo. This review discusses the role of implantable biosensors in closed-loop drug delivery applications, with the intent to provide a resource for engineers and researchers studying such systems. We provide an overview of common biosensor designs and review the principle challenges in implementing long indwelling sensors: namely device sensitivity, selectivity, and lifetime. This review examines novel advances in transducer design, biological interface, and material biocompatibility, with a focus on recent academic and commercial work which provide successful strategies to overcome perennial challenges. This review focuses primarily on the topics of closed-loop glucose control and continuous glucose monitoring biosensors, which make up the overwhelming majority of published research in this area. We conclude with an overview of recent advances in closed-loop systems targeting applications outside blood glucose management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foreign body reaction to biomaterials
Anderson, J. M., Rodriguez, A., & Chang, D. T. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.11.004 · Cited by 5,138
Electrochemical Glucose Biosensors
Wang, J. (2008) · Chemical Reviews · doi:10.1021/cr068123a · Cited by 3,498 · cited 3×
“While use of mediators is common in the design of ex vivo sensors, second generation glucose sensors have seem limited deployment for in vivo applications due to concerns of mediator stability and possible toxicity (Wang, 2008).”
BackgroundMethodVeiseh, O., Doloff, J. C., Ma, M., Vegas, A. J., Tam, H. H., Bader, A. R., Li, J., Langan, E., Wyckoff, J., Loo, W. S., et al. (2015) · Nature Materials · doi:10.1038/nmat4290 · Cited by 897
Imani, S., Bandodkar, A. J., Mohan, A. M. V., Kumar, R., Yu, S., Wang, J., & Mercier, P. P. (2016) · Nature Communications · doi:10.1038/ncomms11650 · Cited by 861
The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685
Biosensors for real-time in vivo measurements
Wilson, G. S., & Gifford, R. (2005) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2004.12.003 · Cited by 660
Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes
Bergenstal, R. M., Garg, S., Weinzimer, S. A., Buckingham, B. A., Bode, B. W., Tamborlane, W. V., & Kaufman, F. R. (2016) · JAMA · doi:10.1001/jama.2016.11708 · Cited by 644 · cited 1×
“of clinical studies have explored ad hoc closed-loop systems comprising a mix of research and commercial devices (Bergenstal et al., 2016; Kovatchev et al., 2014; Kropff et al., 2015; Leelarathna et al., 2014; Renard et al., 2016; Tauschmann et al., 2016; Thabit et al., 2014; Thabit et al., 2015).”
BackgroundFernandez-Real, J.-M., Vayreda, M., Richart, C., Gutierrez, C., Broch, M., Vendrell, J., & Ricart, W. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7305 · Cited by 567
Methods for reducing biosensor membrane biofouling
Wisniewski, N., & Reichert, M. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00148-4 · Cited by 543
Home Use of an Artificial Beta Cell in Type 1 Diabetes
Thabit, H., Tauschmann, M., Allen, J. M., Leelarathna, L., Hartnell, S., Wilinska, M. E., Acerini, C. L., Dellweg, S., Benesch, C., Heinemann, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509351 · Cited by 450
Cited by
Device integration of electrochemical biosensors
Wu, J., Liu, H., Chen, W., Ma, B., & Ju, H. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00032-w · Cited by 895
Electrochemical glucose sensors in diabetes management: an updated review (2010–2020)
Teymourian, H., Barfidokht, A., & Wang, J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00304b · Cited by 881
Wireless and battery-free technologies for neuroengineering
Won, S. M., Cai, L., Gutruf, P., & Rogers, J. A. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00683-3 · Cited by 360
Zhang, D., Chen, Q., Shi, C., Chen, M., Ma, K., Wan, J., & Liu, R. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202007226 · Cited by 303
Stimuli-responsive transdermal microneedle patches
Makvandi, P., Jamaledin, R., Chen, G., Baghbantaraghdari, Z., Zare, E. N., Di Natale, C., Onesto, V., Vecchione, R., Lee, J., Tay, F. R., et al. (2021) · Materials Today · doi:10.1016/j.mattod.2021.03.012 · Cited by 283
Metadata
- Authors
- Scholten, K., & Meng, E.
- Venue
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 544
- Issue
- 2
- Pages
- 319-334
- ISSN
- 0378-5173 (ISSN-L)
- OpenAlex
- W2791879669
- Cited by
- 102
- References
- 36
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A review of implantable biosensors for closed-loop glucose control and other drug delivery applications. https://app.cochat.ai/papers/10.1016/j.ijpharm.2018.02.022
- The paper
- Scholten, K., & Meng, E. (2018). A review of implantable biosensors for closed-loop glucose control and other drug delivery applications. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2018.02.022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.